FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the months of May and June 2004
Commission File No. 000-19865
CEDARA SOFTWARE CORP.
(Registrant's name)
6509 AIRPORT ROAD
MISSISSAUGA, ONTARIO, CANADA L4V 1S7
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40F.
Form 20-F X Form 40-F
---------------- ----------------
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes No X
------------------ ------------------
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b) : 82-_______________
DOCUMENTS INCLUDED AS PART OF THIS REPORT
NO. DOCUMENT
1. PRESS RELEASE DATED JUNE 16, 2004 - CEDARA SOFTWARE ANNOUNCES
PARTNERSHIP WITH MEDIPATTERN CORPORATION
2. PRESS RELEASE DATED MAY 31, 2004 - CEDARA OPENS NEW OFFICE IN CHINA
3. PRESS RELEASE DATED MAY 25, 2004 -CEDARA PARTNERS WITH SCIENCE NORTH
IN DEVELOPING A NEW INTERACTIVE MEDICAL DIAGNOSTIC IMAGING EXHIBIT
4. PRESS RELEASE DATED MAY 19, 2004 - FISCHER IMAGING TO OFFER CEDARA
I-READMAMMO(TM) SOFTWARE WITH ITS SENOSCAN(R)DIGITAL MAMMOGRAPHY
SCANNING SYSTEM.
5. PRESS RELEASE DATED MAY 18, 2004 - CEDARA RECEIVES FDA CLEARANCE FOR
NEW DIGITAL MAMMOGRAPHY WORKSTATION.
6. PRESS RELEASE DATED MAY 13, 2004 - CEDARA FEATURES WEB-BASED MEDICAL
IMAGING SOLUTIONS AT SCAR 2004
Document 1
[Cedara Graphic omitted]
FOR IMMEDIATE RELEASE:
CONTACT: News Release
Chris Barlow, Director of
Business Development
Cedara Software Corp.
(905) 672-2100 ext. 2230
info@cedara.com
Cedara Software Announces Partnership with
Medipattern Corporation
o CEDARA TO ASSIST IN COMMERCIALIZATION AND WORLDWIDE DISTRIBUTION OF
MEDIPATTERN'S NEW COMPUTER AIDED DIAGNOSIS (CAD) SOFTWARE FOR BREAST
ULTRASOUND IMAGING
o ECONOMICAL NEW WEAPON FOR MORE ACCURATE DIAGNOSIS OF BREAST CANCER
WHICH COULD ALSO REDUCE THE NEED FOR PAINFUL AND COSTLY BIOPSIES
o CEDARA TO ALSO HAVE SMALL EQUITY STAKE IN MEDIPATTERN
TORONTO, June 16, 2004 -- Cedara Software Corp. (TSX:CDE/OTCBB:CDSWF) a leading
independent developer of medical software technologies for the global
healthcare market, today announced a strategic partnership with Medipattern
Corporation.
Under the terms of the partnership agreement Cedara will be the exclusive
global channel for Medipattern's breast ultrasound computer aided diagnosis
(CAD) and detection technology. Cedara will use its extensive industry contacts
to promote and market this technology to medical imaging companies worldwide.
Cedara will also integrate Medipattern's CAD technology into its existing
families of mammography and ultrasound products and will market these directly
with end-users such as hospitals, imaging centres, radiologists and physicians.
The companies will work together in completing and commercializing the
technology. In particular, Cedara will assist with marketing and product
management; validation and engineering; regulatory management; technical
authoring and hot-line support services. Cedara will also have a small equity
stake in Medipattern.
"Cedara has the ability to take Medipattern's CAD technology and form a set of
compelling solutions for breast ultrasound that have the potential to transform
the breast imaging landscape," said Jeff Collins, CEO of Medipattern
Corporation. "Cedara also has the contacts and relationships to get this
technology in front of every major ultrasound manufacturer and mammography
company. Given Cedara's history and credentials with original equipment
manufacturers (OEMs) we expect that market interest will be strong."
The partnership with Medipattern is another success of Cedara's Technology
Partnership Program, announced in November 2003 as a mechanism for the
selection of innovative companies and technologies, and their promotion and
distribution through Cedara's worldwide channels. Cedara Software recently
announced United States FDA clearance of its Cedara I-ReadMammo (TM)
mammography workstation, one of the first products that Cedara plans to enhance
with Medipattern's new CAD technology.
"Cedara Software has a unique position in the medical imaging community," said
Abe Schwartz Cedara's President and CEO. "We are independent, well-connected
and respected as a committed partner and technology leader. This makes Cedara a
tremendous launch vehicle for Medipattern's technology and success - a success
in which we will all share."
For more information on Cedara Software, please visit the Cedara Website at
www.cedara.com or contact:
Chris Barlow Jeff Collins
Director of Business Development Chief Executive Officer
Cedara Software Corp., Medipattern Corporation
(905) 672-2100 ext. 2230. (416) 744-0009 ext. 224
Email: info@cedara.com. Email: jcollins@medipattern.com
For investor-related inquiries, please contact:
Brian Pedlar, Chief Financial Officer
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com
ABOUT MEDIPATTERN CORPORATION:
The Medipattern Corporation, a private company located in Toronto, develops
Computer Aided Diagnostic (CAD) software applications for medical imaging.
Medipattern's flagship product, B-CAD, is a software platform capable of
applying knowledge to digital images. It assists radiologists in their efforts
to distinguish between benign and malignant lesions in ultrasound images of the
breast.
ABOUT CEDARA SOFTWARE:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in hospitals and clinics
worldwide - approximately 20,000 medical imaging systems and 4,600 Picture
Archiving and Communications System (PACS) workstations have been licensed to
date. Cedara is enabling the future of the healthcare industry with new
innovative approaches to workflow, data and image management, integration, the
web, software components and professional services. The Company's medical
imaging solutions are used in all aspects of clinical workflow including the
capture of patient digital images; the sharing and archiving of images;
sophisticated tools to analyze and manipulate images; and even the use of
imaging in surgery. Cedara is unique in that it has expertise and technologies
that span all the major digital imaging modalities including angiography,
computed tomography (CT), echo-cardiology, digital X-ray, fluoroscopy,
mammography, magnetic resonance imaging (MRI), nuclear medicine, positron
emission tomography (PET) and ultrasound.
Certain statements contained in this news release are forward-looking and are
based on current expectations that are subject to a number of uncertainties and
risks, and actual results may differ materially. These uncertainties and risks
include, but are not limited to: the management of the growth of the Company,
dependence on key personnel of the Company, competitive pressures (including
price competition), changes in market activity, risks associated with
international operations, the development of new products and services, the
enhancement of existing products and services, the introduction of competing
products having technological and/or other advantages, the dependence on key
customers, regulatory changes to the health care industry, seasonality,
economic and political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of Cedara Software
Corp.
Document 2
[Cedara Graphic omitted]
FOR IMMEDIATE RELEASE:
CONTACT: News Release
Michelle Pommells, Director Product
Communications
Cedara Software Corp.
(905) 672-2100 ext. 2356
info@cedara.com
Cedara Opens New Office in China
SHANGHAI, China, May 31st, 2004 -- Cedara Software Corp. (TSX:CDE/OTCBB:CDSWF),
a leading independent developer of medical software technologies for the global
healthcare market, today announced it has opened a new office in Shanghai to
better serve its existing customers and successfully pursue new business
opportunities in China.
Cedara's Picture Archiving and Communications System (PACS) products are
already sold by some of the country's leading medical equipment manufacturers.
The opening of a Chinese office is another step towards Cedara establishing a
larger presence in the region.
"China presents a great market opportunity for Cedara. Opening an office in
China gives us a direct presence on the mainland and an excellent opportunity
for growth in the Asia-Pacific region," said Abe Schwartz, Cedara's President
and CEO. "We believe that Cedara's vast medical imaging software solutions can
help to improve the delivery of healthcare for the people of China."
The new office, located in the prestigious Pudong Software Park, is run by Mr.
Minglin Li, Cedara General Manager, Greater China. It will provide local sales,
support and training to Cedara's Chinese customer base as well as customers in
the Asia-Pacific region, enabling it to work more closely with clients and
hospitals in the area. The office will also be staffed to offer engineering
services to customers as well as perform research and development on Cedara
products.
"We chose Shanghai as our base in China because of its central location, ease
of access to existing customers, links with foreign companies and the
availability of skilled engineers," Li said. " We can now provide a quicker
response for our customers in China and in the Asia-Pacific region because we
are in such close proximity to them. Localized products and services will make
Cedara more competitive in the large Chinese market and provide better service
to users," he stated.
"The opening of the Shanghai office is an important milestone for Cedara's
business in China. As a partner, Cedara has always been a great help to our
business. Now with their local presence, we have a much better chance of
enhancing our success in the Chinese market by leveraging Cedara's remarkable
technology," said Mr. Yaokang Chen, General Manager of Shanghai Medical
Equipment Works Co., Ltd.
"We are very pleased to have Cedara as an international technology leader in
our high tech development zone. Their medical industry software experience will
enrich the overall technology environment in this area, and will help China
catch up with the most advanced medical imaging technology in the world," said
Mr. Ao Zhang, Vice Chairman of the Science & Technology Commission, Shanghai
Municipality.
For more information about Cedara Software, visit www.cedara.com
For more information about Cedara China, contact:
Minglin Li, Cedara General Manager, Greater China
Suite 1411
498 GuoShouJing Road
Pudong Software Park
Shanghai 201203
Tel: 86-21-5027-0600
Fax: 86-21-5027-0382
Email: info@cedara.com.
For investor-related inquiries, contact:
Brian Pedlar, Chief Financial Officer
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com
ABOUT CEDARA SOFTWARE:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in thousands of hospitals and
clinics worldwide. Cedara's advanced medical imaging technologies are used in
all aspects of clinical workflow including the operator consoles of numerous
medical imaging devices; Picture Archiving and Communications Systems (PACS);
sophisticated clinical applications that further analyze and manipulate images;
and even the use of imaging in minimally-invasive surgery. Cedara is unique in
that it has expertise and technologies that span all the major digital imaging
modalities including magnetic resonance imaging (MRI), computed tomography
(CT), digital X-ray, ultrasound, mammography, cardiology, nuclear medicine,
angiography, positron emission tomography (PET) and fluoroscopy.
Certain statements contained in this news release are forward-looking and are
based on current expectations that are subject to a number of uncertainties and
risks, and actual results may differ materially. These uncertainties and risks
include, but are not limited to: the management of the growth of the Company,
dependence on key personnel of the Company, competitive pressures (including
price competition), changes in market activity, risks associated with
international operations, the development of new products and services, the
enhancement of existing products and services, the introduction of competing
products having technological and/or other advantages, the dependence on key
customers, regulatory changes to the health care industry, seasonality,
economic and political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of Cedara Software
Corp.
Document 3
[Cedara Graphic omitted]
FOR IMMEDIATE RELEASE:
CONTACT: News Release
Michelle Pommells, Director Product Communications
Cedara Software Corp.
(905) 672-2100 ext. 2356
info@cedara.com
Cedara Partners with Science North in Developing a New Interactive
Medical Diagnostic Imaging Exhibit
TORONTO, May 25, 2004 -- Cedara Software Corp. (TSX:CDE/OTCBB:CDSWF), a leading
independent developer of medical software technologies for the global
healthcare market, announced today it has partnered with Science North in the
creation of a new medical diagnostic imaging exhibit.
Science North is a government of Ontario Ministry of Culture agency that is
internationally recognized as one of Canada's leading science centres. One of
Northern Ontario's most popular tourist attractions, Science North's new Human
Machine exhibit is intended to educate the general public about the human body,
inviting children and their families to discover how patient images can help
Doctors identify medical problems.
Cedara has contributed two diagnostic medical imaging components to the Human
Machine exhibit. The first component lets the general public act like Doctors.
The patient describes different ailments, such as a sore back or stomach pain
and the "doctor" orders tests using Magnetic Resonance Imaging (MRI),
Computerized Axial Tomography (CAT), Ultrasound, or another major diagnostic
imaging modality. Cedara images show what the tests reveal and the interactive
video explains the diagnosis. The second component is a self-paced;
multiple-choice quiz that challenges participants to examine real images and
then select the appropriate answer. This fun quiz can be accessed on Cedara's
web site at www.cedara.com.
"Our Human Machine exhibit is a big hit with families. It's great fun providing
plenty of hands-on activities for everyone. The excellent quality of the images
and realistic clinical scenarios provided by Cedara helps make this a must-see
exhibit," said Jennifer Pink, Senior Scientist for Science North.
"Cedara enjoyed the opportunity to work with Science North on creating such an
exciting new exhibit. The Human Machine exhibit provides a cool way for us to
take some of the mystery out of what Doctor's do and gives the general public a
better appreciation of what is involved in medical imaging," said George
Keramidopulos, Cedara's Director of Business Development.
The Human Machine exhibit at Science North in Sudbury, Ontario is now on
display in the Special Exhibits Hall until September 6, 2004, and expects to
attract thousands of visitors over the ensuing months. Following this, the
exhibit will be moved to a permanent gallery in the science centre. Science
North is also exploring the possibility of packaging the exhibit so that it can
be shown at other science centres throughout the world.
For more information about Cedara, visit the Cedara website at www.cedara.com
or contact:
Michelle Pommells, Cedara Software Corp.,
(905) 672-2100 ext. 2356.
Email: info@cedara.com.
For investor-related inquiries, contact:
Brian Pedlar, Chief Financial Officer
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com
ABOUT CEDARA SOFTWARE:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in thousands of hospitals and
clinics worldwide. Cedara's advanced medical imaging technologies are used in
all aspects of clinical workflow including the operator consoles of numerous
medical imaging devices; Picture Archiving and Communications Systems (PACS);
sophisticated clinical applications that further analyze and manipulate images;
and even the use of imaging in minimally-invasive surgery. Cedara is unique in
that it has expertise and technologies that span all the major digital imaging
modalities including magnetic resonance imaging (MRI), computed tomography
(CT), digital X-ray, ultrasound, mammography, cardiology, nuclear medicine,
angiography, positron emission tomography (PET) and fluoroscopy.
ABOUT SCIENCE NORTH
Science North, located in Sudbury, Ontario, Canada is celebrating its 20th year
as a world leader in science education and communication. Science North's
attractions include the Science Centre, a 200-seat IMAX Theatre, a Virtual
Voyages adventure ride, and Dynamic Earth, a new earth sciences centre. Over
the past five years, Science North has established itself as a leading
developer of interactive exhibits for museums and science centres worldwide.
Certain statements contained in this news release are forward-looking and are
based on current expectations that are subject to a number of uncertainties and
risks, and actual results may differ materially. These uncertainties and risks
include, but are not limited to: the management of the growth of the Company,
dependence on key personnel of the Company, competitive pressures (including
price competition), changes in market activity, risks associated with
international operations, the development of new products and services, the
enhancement of existing products and services, the introduction of competing
products having technological and/or other advantages, the dependence on key
customers, regulatory changes to the health care industry, seasonality,
economic and political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of Cedara Software
Corp.
Document 4
[Cedara Graphic omitted]
FOR IMMEDIATE RELEASE:
CONTACT: News Release
Michelle Pommells, Director Product Communications
Cedara Software Corp.
(905) 672-2100 ext. 2356
info@cedara.com
Fischer Imaging to Offer Cedara I-ReadMammo(TM)Software with its SenoScan(R)
Digital Mammography Scanning System
Fischer Imaging Corporation (FIMG:PK) and Cedara Software Corp.
(TSX:CDE/OTCBB:CDSWF) today announced that they have entered into a cooperative
sales, marketing and support agreement to integrate a customized version of
Cedara's new Cedara I-ReadMammo(TM) workstation software with Fischer's
SenoScan(R) digital mammography scanning system.
I-ReadMammo is a dedicated mammography workstation software system and an
extension of Cedara's well-regarded Cedara I-SoftView(TM) PACS multi-modality
workstation. This partnership expands the family of softcopy workstations
offered by Fischer. In addition to its current workstation, Fischer will now
offer its customers the I-ReadMammo-based SenoView dedicated mammography
softcopy workstation. For more advanced applications, where multi-modality
image display and review are required, Fischer will offer the SenoView Plus,
combining both the I-ReadMammo and I-SoftView Cedara software.
Together, they allow radiologists to compare SenoScan digital images with other
modality images, such as ultrasound, nuclear medicine and MRIs. The net result
is the ability to deliver improved workflow and reading efficiency compared
with traditional film screen mammography systems.
"A key goal in our drive to become the leader in women's healthcare is to
provide both the most effective and the easiest-to-use systems on the market,"
said Harris Ravine, Fischer Imaging president and CEO. "In consideration of our
immediate and long term workstation requirements, we chose Cedara because of
their expertise in the area of PACS software design and their knowledge of
workflow. Given Fischer's core competency in digital mammography, the
relationship made perfect sense. Partnering with Cedara enables us to offer the
radiologist outstanding softcopy workstation workflow capabilities that will
improve their productivity and enhance patient care."
"We are delighted to be working with Fischer, a pioneer and leader in the field
of digital mammography," said Abe Schwartz, Cedara president and CEO. "We
believe our superior workflow technology combined with Fischer's innovative
digital mammography systems make for a winning combination." About Cedara
Software
Headquartered in Toronto, Canada, Cedara Software Corp. is a leading
independent provider of medical technologies for many of the world's leading
medical device and healthcare information technology companies. Cedara software
is deployed in thousands of hospitals and clinics worldwide. Cedara's advanced
medical imaging technologies are used in all aspects of clinical workflow
including the operator consoles of numerous medical imaging devices; Picture
Archiving and Communications Systems (PACS); sophisticated clinical
applications that further analyze and manipulate images; and even the use of
imaging in minimally-invasive surgery. Cedara is unique in that it has
expertise and technologies that span all the major digital imaging modalities
including magnetic resonance imaging (MRI), computed tomography (CT), digital
X-ray, ultrasound, mammography, cardiology, nuclear medicine, angiography,
positron emission tomography (PET) and fluoroscopy. For more information, visit
www.cedara.com.
About Fischer Imaging
Fischer Imaging Corporation designs, manufactures and markets medical imaging
systems for the screening and diagnosis of disease. The company focuses on
women's health, particularly the diagnosis and screening of breast cancer
through the application of innovative digital imaging technologies. Fischer
Imaging began producing general-purpose x-ray imaging systems in 1910 and is
the oldest manufacturer of x-ray imaging devices in the United States. For more
information, visit www.fischerimaging.com.
For more information about Cedara, visit the Cedara website at www.cedara.com
or contact:
Michelle Pommells, Cedara Software Corp.,
(905) 672-2100 ext. 2356.
Email: info@cedara.com.
For investor-related inquiries, contact:
Brian Pedlar, Chief Financial Officer
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com
ABOUT CEDARA SOFTWARE:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in thousands of hospitals and
clinics worldwide. Cedara's advanced medical imaging technologies are used in
all aspects of clinical workflow including the operator consoles of numerous
medical imaging devices; Picture Archiving and Communications Systems (PACS);
sophisticated clinical applications that further analyze and manipulate images;
and even the use of imaging in minimally-invasive surgery. Cedara is unique in
that it has expertise and technologies that span all the major digital imaging
modalities including magnetic resonance imaging (MRI), computed tomography
(CT), digital X-ray, ultrasound, mammography, cardiology, nuclear medicine,
angiography, positron emission tomography (PET) and fluoroscopy.
Certain statements contained in this news release are forward-looking and are
based on current expectations that are subject to a number of uncertainties and
risks, and actual results may differ materially. These uncertainties and risks
include, but are not limited to: the management of the growth of the Company,
dependence on key personnel of the Company, competitive pressures (including
price competition), changes in market activity, risks associated with
international operations, the development of new products and services, the
enhancement of existing products and services, the introduction of competing
products having technological and/or other advantages, the dependence on key
customers, regulatory changes to the health care industry, seasonality,
economic and political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of Cedara Software
Corp.
Document 5
[Cedara Graphic omitted]
FOR IMMEDIATE RELEASE:
CONTACT: News Release
Michelle Pommells,
Director Product Communications
Cedara Software Corp.
(905) 672-2100 ext. 2356 info@cedara.com
Cedara Receives FDA Clearance
for New Digital Mammography Workstation
o ELIMINATES THE NEED TO SWITCH BETWEEN DIFFERENT WORKSTATIONS BY
SUPPORTING MAMMOGRAPHY SYSTEMS FROM MULTIPLE VENDORS ON A SINGLE
WORKSTATION
o SAVES READING TIME ALLOWING RADIOLOGISTS TO VIEW IMAGES FROM MULTIPLE
MODALITIES
o EASILY INTEGRATES WITH CEDARA'S FILM DIGITIZING APPLICATION FOR VIEWING
OLD FILM IMAGES WITH NEW DIGITAL IMAGES
TORONTO, May 18, 2004 -- Cedara Software Corp. (TSX:CDE/OTCBB:CDSWF), a leading
independent developer of medical software technologies for the global
healthcare market, today announced that it has received U.S. Food and Drug
Administration (FDA) 510(k) clearance for Cedara I-ReadMammo(TM), its new
mammography reading workstation for diagnosis and screening.
There has been a surge in the use of digital mammography which is expected to
play a major role in mammography screening. It is estimated that only a small
percentage of the current mammography installed base is digital, which
represents a huge growth opportunity. FDA clearance allows Cedara to sell
I-ReadMammo into the US, which currently is the largest market for mammography,
and one of the fastest growing digital mammography markets in the world.
"We are very excited about offering the Cedara I-ReadMammo solution in the
United States, which tragically has one of the highest breast cancer rates in
the world. We believe this product can make a big difference in the fight
against breast cancer by advancing the way radiologists work," said Sabrina
Cannistraro, Cedara Segment Manager for Women's Health.
Tests of the Cedara I-ReadMammo workstation have been performed in cooperation
with a number of mammography centers around the world, including the Elizabeth
Wende Breast Clinic in the USA, Lund University Hospital in Sweden, and
Burlington Ultrasound and Radiology Clinic in Canada.
"The Cedara I-ReadMammo soft copy review workstation is user friendly and
remarkably versatile. The options for image display and worklist manipulation
are well thought out even for the busiest of women's health practices," stated
Margarita L. Zuley, M.D. from The Elizabeth Wende Breast Clinic, well known in
the industry as one of the first women's centers of its kind.
Having the ability to read images from mammography systems from multiple vendor
FFDM (Full Field Digital Mammography) products on a single I-ReadMammo
workstation is a real advantage to busy radiologists who presently have to keep
switching between multiple systems.
In addition to traditional x-ray images, Ultrasound and MRI are becoming more
prevalent in breast cancer diagnosis. Having a multi-modality mammography
workstation, like Cedara I-ReadMammo, that handles not only X-ray mammography
images, but also all other relevant modalities is critical.
Mammography centers transitioning to digital imaging still need to view prior
images on film. This makes it difficult for radiologists to compare prior
images with new digital images because they can no longer be placed
side-by-side. Cedara I-ReadMammo is the only workstation that integrates easily
with a film digitizing application allowing radiologists to view current and
prior images in a single format on a single workstation.
"Cedara spent nearly two years talking with radiologists to understand the
mammography workflow before building the Cedara I-ReadMammo workstation," said
Dr. Bruce Davey, Cedara Director of Medical Applications. "From the
enthusiastic response of radiologists, it's a very hot product," Davey said.
"It's definitely the most optimized solution for viewing digital mammography
images on the market."
The FDA cleared workstation is part of Cedara's complete Picture Archiving and
Communication System (PACS) solution enabling Mammography departments to easily
share information with the rest of Radiology.
For more information about Cedara I-ReadMammo, visit the Cedara Website at
www.cedara.com or contact:
Michelle Pommells, Cedara Software Corp.,
(905) 672-2100 ext. 2356.
Email: info@cedara.com.
For investor-related inquiries, contact:
Brian Pedlar, Chief Financial Officer
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com
ABOUT CEDARA SOFTWARE:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in thousands of hospitals and
clinics worldwide. Cedara's advanced medical imaging technologies are used in
all aspects of clinical workflow including the operator consoles of numerous
medical imaging devices; Picture Archiving and Communications Systems (PACS);
sophisticated clinical applications that further analyze and manipulate images;
and even the use of imaging in minimally-invasive surgery. Cedara is unique in
that it has expertise and technologies that span all the major digital imaging
modalities including magnetic resonance imaging (MRI), computed tomography
(CT), digital X-ray, ultrasound, mammography, cardiology, nuclear medicine,
angiography, positron emission tomography (PET) and fluoroscopy.
Certain statements contained in this news release are forward-looking and are
based on current expectations that are subject to a number of uncertainties and
risks, and actual results may differ materially. These uncertainties and risks
include, but are not limited to: the management of the growth of the Company,
dependence on key personnel of the Company, competitive pressures (including
price competition), changes in market activity, risks associated with
international operations, the development of new products and services, the
enhancement of existing products and services, the introduction of competing
products having technological and/or other advantages, the dependence on key
customers, regulatory changes to the health care industry, seasonality,
economic and political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of Cedara Software
Corp.
Document 6
[Cedara Graphic omitted]
FOR IMMEDIATE RELEASE:
CONTACT: News Release
Michelle Pommells, Director Product Communications
Cedara Software Corp.
(905) 672-2100 ext. 2356
info@cedara.com
CEDARA FEATURES WEB-BASED MEDICAL IMAGING SOLUTIONS AT SCAR 2004
o SOCIETY FOR COMPUTER APPLICATIONS IN RADIOLOGY (SCAR) 2004 IS THE IDEAL
SETTING TO SHOWCASE CEDARA SOLUTIONS FOR REMOTE TELERADIOLOGY VIEWING,
EFFICIENT HANDLING OF LARGE MULTI-SLICE CT DATA VOLUMES, MULTI-MODALITY
DIGITAL MAMMOGRAPHY SCREENING, ORTHOPEDIC PLANNING, AND AUTOMATIC 3D
SEGMENTATION
TORONTO, May 13, 2004 -- Cedara Software Corp. (TSX:CDE/OTCBB:CDSWF) a leading
independent developer of medical software technologies for the global
healthcare market announced plans to present its latest Web imaging solutions
at the 2004 Society for Computer Applications in Radiology 21st annual meeting
on May 20th in Vancouver, British Columbia, Canada.
Held at the Vancouver Convention and Exhibition Center, Vancouver, Canada, May
20 - 23, SCAR is the leading technology conference for radiology professionals.
The symposium attracts radiologists, radiology business managers and imaging
center professionals, among others.
Cedara will present a host of web-ready products during the annual event,
including its latest Web PACS solutions for remote radiology viewing in
addition to an array of clinical applications that integrate seamlessly with
its PACS (Picture Archiving and Communications System) workstation. By
integrating clinical packages, Cedara increases the usefulness of PACS.
Radiologists and other specialists can launch Cedara orthopedic planning,
digital mammography screening, 3D, and other applications, directly from a
single PACS workstation without having to invest in multiple workstations.
"Any hospital or medical device manufacturer interested in the very latest in
radiology solutions will want to check out the most unique technology on the
market," said Jacques Cornet, Cedara Vice President of Marketing and
Operations. "I think they'll be impressed with how our engineers have managed
to solve even the most difficult clinical workflow challenges, in ways that
aren't available on any other product range," he stated.
Cedara will showcase a number of its latest technologies:
>> CEDARA I-REPORT CT(TM), a multi-slice CT navigation and reporting
workstation for the very largest of multi-slice data sets. Features
include reviewing images in stack mode using MPR (Multi-planar
Reformat), MIP (Minimum Intensity Projection), and volume rendering
modes, which greatly improves radiologist's ability to navigate large
data volumes.
>> CEDARA I-READMAMMO(TM), a multi-modality digital mammography
workstation with state-of-the art performance for improving
mammography workflow. Features include automating the presentation
procedure and review process for current and prior mammography images
to save critical reading time.
>> CEDARA ORTHOWORKS(TM), a complete orthopedic treatment and digital
planning solution that provides orthopedists the digital tools they
need to accurately plan treatment and surgery and reduce the support
costs of adding new implant templates. OrthoWorks integrates with
Cedara I-Acquire to support image acquisition from all orthopedic
modalities, including CT, MRI, CR, DR and film digitizers, and uses
Web Server software to enable Internet-based orthopedic planning.
>> CEDARA'S NEW TISSUE TYPE SEGMENTATION SOFTWARE provides fully
automatic and semi-automatic identification of tissue structures and
organs for 2D and 3D MRI and CT data. The software can be used to
build a variety of clinical applications that require fast, reliable
automated analysis of anatomical structures, including cardio vascular
structures. The cardiology package goes from MRI data selection to a
complete 3D model, in one mouse click. Cedara's Tissue Type
Segmentation software can be applied to specific anatomy using
Cedara's sophisticated 3D capability and imaging algorithms that can
intelligently learn from the data.
Also to be shown at SCAR:
>> CEDARA I-REACH(TM), a fully diagnostic web PACS that addresses the
teleradiology needs of single departments or the entire hospital
enterprise. With this system, surgeons, radiologists, specialists, and
physicians can access patient information and images from anywhere in
a hospital, or external health network, over the Internet.
>> CEDARA I-CONFERENCE(TM), Cedara's innovative new clinical consultation
application that streamlines the preparation of clinical
presentations, is also being featured by Barco this year, as part of
its SCAR 2004 DICOM Theatre(R) display, the world's first medical
grade large screen projection system. Barco designs and develops
solutions for large screen visualization, display solutions for
life-critical applications, and systems for visual inspection.
For more information on these products, visit Cedara at the Society for
Computer Applications in Radiology 21st annual meeting, May 20 - 23, booth 724,
at the Vancouver Convention and Exhibition Center, Vancouver, British Columbia,
Canada.
For information about Cedara's complete range of medical imaging products,
visit the Cedara website at www.cedara.com. Or contact:
Michelle Pommells, Cedara Software Corp.
(905) 672-2100 ext. 2356
Email: info@cedara.com
For investor-related inquiries, contact:
Brian Pedlar, Chief Financial Officer and Corporate Secretary
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com
ABOUT CEDARA SOFTWARE:
Cedara Software Corp. is a leading independent provider of medical technologies
for many of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in thousands of hospitals and
clinics worldwide. Cedara's advanced medical imaging technologies are used in
all aspects of clinical workflow including the operator consoles of numerous
medical imaging devices; Picture Archiving and Communications Systems (PACS);
sophisticated clinical applications that further analyze and manipulate images;
and even the use of imaging in minimally-invasive surgery. Cedara is unique in
that it has expertise and technologies that span all the major digital imaging
modalities including magnetic resonance imaging (MRI), computed tomography
(CT), digital X-ray, ultrasound, mammography, cardiology, nuclear medicine,
angiography, positron emission tomography (PET) and fluoroscopy.
Certain statements contained in this news release are forward-looking and are
based on current expectations that are subject to a number of uncertainties and
risks, and actual results may differ materially. These uncertainties and risks
include, but are not limited to: the management of the growth of the Company,
dependence on key personnel of the Company, competitive pressures (including
price competition), changes in market activity, risks associated with
international operations, the development of new products and services, the
enhancement of existing products and services, the introduction of competing
products having technological and/or other advantages, the dependence on key
customers, regulatory changes to the health care industry, seasonality,
economic and political conditions and adequate protection of the proprietary
interests of the Company. Further information about these risks and
uncertainties can be found in the continuous disclosure documents filed from
time to time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/.
All trademarks appearing in this release are the property of Cedara Software
Corp.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
June 28, 2004
CEDARA SOFTWARE CORP.
By: /s/ Brian Pedlar
--------------------
Brian Pedlar
Chief Financial Officer